News
Danish pharmaceutical giant Novo Nordisk is set to lose Canadian patent protection on its popular semaglutide-based drugs, ...
1h
India Today on MSNAyurveda's 'Natural Ozempic': The truth about berberine for weight lossThe surrounding buzz is deafening, fuelled by incredible claims of effortless weight loss. But while berberine, or Daru Haldi ...
Tech expert Trevor Long discusses Samsung’s “remarkable” seventh generation of their foldable smartphone range. “The fold ...
It’s clear markets don’t believe Trump’s tariff threats will become reality. This is the so-called TACO trade, a notion ...
StockStory.org on MSN19h
Hims & Hers Health (HIMS) Stock Is Up, What You Need To KnowWhat Happened? Shares of telehealth company Hims & Hers Health (NYSE:HIMS) jumped 4.1% in the morning session after the ...
Novo Nordisk's beaten-down valuation became too attractive to pass up, so I bought the stock earlier this year. Eli Lilly's ...
Hims & Hers announced plans to expand its weight loss program to Canada in 2026 in connection with the availability of generic semaglutide anywhere in the world.
18h
Live Science on MSNWeight loss may 'rejuvenate' fat tissues, clearing away aged cellsWeight loss is known to improve health in obesity. A new study provides clues to how: by rejuvenating fat tissue and changing ...
SAMSUNG is back with more foldable smartphones and this time I think they’ve nailed this risky move. The South Korean firm ...
18h
Live Science on MSNMetformin may prevent severe morning sicknessTaking the diabetes drug metformin before pregnancy may reduce the risk of debilitating morning sickness by 70%, early data ...
Health Canada is advising that the following product(s) may pose serious health risks. For more information, including product photos and what you should do, visit these online safety alerts: ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results